Cargando…
Long-term results of curative intraluminal high dose rate brachytherapy for endobronchial carcinoma
BACKGROUND: The treatment strategy of central lung tumors is not established. Intraluminal brachytherapy (ILBT) is widely used for palliative treatment of endobronchial tumors, however, it is also a promising option for curative treatment with limited data. This study evaluates the results after ILB...
Autores principales: | Kawamura, Hidemasa, Ebara, Takeshi, Katoh, Hiroyuki, Tamaki, Tomoaki, Ishikawa, Hitoshi, Sakurai, Hideyuki, Nakano, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411402/ https://www.ncbi.nlm.nih.gov/pubmed/22824158 http://dx.doi.org/10.1186/1748-717X-7-112 |
Ejemplares similares
-
Radiologically Occult Lung Cancer Curatively Treated with High-Dose Rate Endobronchial Brachytherapy
por: Singh, Deepinder Pal, et al.
Publicado: (2021) -
High-dose-rate intraluminal brachytherapy for paraneoplastic autoimmune multiorgan syndrome
por: Lee, Sun-Young, et al.
Publicado: (2016) -
Endobronchial brachytherapy with curative intent: the impact of reference points setting according to the bronchial diameter
por: Nomoto, Yoshihito, et al.
Publicado: (2017) -
High Dose Rate Brachytherapy as a Treatment Option in Endobronchial Tumors
por: Hosni, Ali, et al.
Publicado: (2016) -
Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancer
por: Harada, Kosaku, et al.
Publicado: (2012)